Discover the dual nature of TAp73 protein in cellular stress response and its implications for cancer therapy.
Explore how DNA-Damage Inducible 1 (DDI1) contributes to therapy resistance in non-small cell lung cancer and its potential as a therapeutic target.
Discover how GSK-3 inhibition affects DNA damage response through TopBP1 degradation and its potential for revolutionizing cancer therapy.